Newly Diagnosed Low Grade Glioma

​Trials listed below that do not have a blue link are not currently open to accrual

Protocol #



​RTOG ​Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas

For more information, contact:

Jill Brown


The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: